Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Saved in:
| Title: | Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. |
|---|---|
| Authors: | Xia D; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lianoglou S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sandmann T; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Calvert M; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Suh JH; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thomsen E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Dugas J; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., DeVos SL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Davis S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Ha C; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Nguyen H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Chau R; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Yulyaningsih E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lopez I; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Masoud ST; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Liang CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Astarita G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Khoury N; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Zuchero JY; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.; Department of Pharmaceutics, University of Minnesota, 9-177 Weaver-Densford Hall, 308 Harvard St. SE, Minneapolis, MN, 55455, USA., Shen K; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Miller S; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Palop JJ; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Garceau D; The Jackson Lab, Bar Harbor, Maine, USA., Sasner M; The Jackson Lab, Bar Harbor, Maine, USA., Whitesell JD; Allen Institute for Brain Science, Seattle, Washington, USA., Harris JA; Allen Institute for Brain Science, Seattle, Washington, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Gnörich J; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Wind K; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Kunze L; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Zatcepin A; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Willem M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität, München, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany., Barnett D; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Zimmer TS; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA., Orr AG; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Scearce-Levie K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Di Paolo G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sanchez PE; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA. sanchez@dnli.com. |
| Source: | Molecular neurodegeneration [Mol Neurodegener] 2022 Jun 11; Vol. 17 (1), pp. 41. Date of Electronic Publication: 2022 Jun 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35690868 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xia+D%22">Xia D</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lianoglou+S%22">Lianoglou S</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Sandmann+T%22">Sandmann T</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Calvert+M%22">Calvert M</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Suh+JH%22">Suh JH</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Thomsen+E%22">Thomsen E</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Dugas+J%22">Dugas J</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Pizzo+ME%22">Pizzo ME</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22DeVos+SL%22">DeVos SL</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Earr+TK%22">Earr TK</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Davis+S%22">Davis S</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ha+C%22">Ha C</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Leung+AW%22">Leung AW</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+H%22">Nguyen H</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Chau+R%22">Chau R</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Yulyaningsih+E%22">Yulyaningsih E</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lopez+I%22">Lopez I</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Solanoy+H%22">Solanoy H</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Masoud+ST%22">Masoud ST</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Liang+CC%22">Liang CC</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lin+K%22">Lin K</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Astarita+G%22">Astarita G</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Khoury+N%22">Khoury N</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Zuchero+JY%22">Zuchero JY</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Thorne+RG%22">Thorne RG</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.; Department of Pharmaceutics, University of Minnesota, 9-177 Weaver-Densford Hall, 308 Harvard St. SE, Minneapolis, MN, 55455, USA.<br /><searchLink fieldCode="AU" term="%22Shen+K%22">Shen K</searchLink>; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Miller+S%22">Miller S</searchLink>; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Palop+JJ%22">Palop JJ</searchLink>; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Garceau+D%22">Garceau D</searchLink>; The Jackson Lab, Bar Harbor, Maine, USA.<br /><searchLink fieldCode="AU" term="%22Sasner+M%22">Sasner M</searchLink>; The Jackson Lab, Bar Harbor, Maine, USA.<br /><searchLink fieldCode="AU" term="%22Whitesell+JD%22">Whitesell JD</searchLink>; Allen Institute for Brain Science, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Harris+JA%22">Harris JA</searchLink>; Allen Institute for Brain Science, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Hummel+S%22">Hummel S</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gnörich+J%22">Gnörich J</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wind+K%22">Wind K</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Kunze+L%22">Kunze L</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Zatcepin+A%22">Zatcepin A</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Brendel+M%22">Brendel M</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Willem+M%22">Willem M</searchLink>; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Haass+C%22">Haass C</searchLink>; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität, München, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Barnett+D%22">Barnett D</searchLink>; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Zimmer+TS%22">Zimmer TS</searchLink>; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Orr+AG%22">Orr AG</searchLink>; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Scearce-Levie+K%22">Scearce-Levie K</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lewcock+JW%22">Lewcock JW</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Di+Paolo+G%22">Di Paolo G</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Sanchez+PE%22">Sanchez PE</searchLink>; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA. sanchez@dnli.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101266600%22">Molecular neurodegeneration</searchLink> [Mol Neurodegener] 2022 Jun 11; Vol. 17 (1), pp. 41. <i>Date of Electronic Publication: </i>2022 Jun 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101266600 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217501326%22">17501326 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neurodegener <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35690868 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13024-022-00547-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 41 Titles: – TitleFull: Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xia D – PersonEntity: Name: NameFull: Lianoglou S – PersonEntity: Name: NameFull: Sandmann T – PersonEntity: Name: NameFull: Calvert M – PersonEntity: Name: NameFull: Suh JH – PersonEntity: Name: NameFull: Thomsen E – PersonEntity: Name: NameFull: Dugas J – PersonEntity: Name: NameFull: Pizzo ME – PersonEntity: Name: NameFull: DeVos SL – PersonEntity: Name: NameFull: Earr TK – PersonEntity: Name: NameFull: Lin CC – PersonEntity: Name: NameFull: Davis S – PersonEntity: Name: NameFull: Ha C – PersonEntity: Name: NameFull: Leung AW – PersonEntity: Name: NameFull: Nguyen H – PersonEntity: Name: NameFull: Chau R – PersonEntity: Name: NameFull: Yulyaningsih E – PersonEntity: Name: NameFull: Lopez I – PersonEntity: Name: NameFull: Solanoy H – PersonEntity: Name: NameFull: Masoud ST – PersonEntity: Name: NameFull: Liang CC – PersonEntity: Name: NameFull: Lin K – PersonEntity: Name: NameFull: Astarita G – PersonEntity: Name: NameFull: Khoury N – PersonEntity: Name: NameFull: Zuchero JY – PersonEntity: Name: NameFull: Thorne RG – PersonEntity: Name: NameFull: Shen K – PersonEntity: Name: NameFull: Miller S – PersonEntity: Name: NameFull: Palop JJ – PersonEntity: Name: NameFull: Garceau D – PersonEntity: Name: NameFull: Sasner M – PersonEntity: Name: NameFull: Whitesell JD – PersonEntity: Name: NameFull: Harris JA – PersonEntity: Name: NameFull: Hummel S – PersonEntity: Name: NameFull: Gnörich J – PersonEntity: Name: NameFull: Wind K – PersonEntity: Name: NameFull: Kunze L – PersonEntity: Name: NameFull: Zatcepin A – PersonEntity: Name: NameFull: Brendel M – PersonEntity: Name: NameFull: Willem M – PersonEntity: Name: NameFull: Haass C – PersonEntity: Name: NameFull: Barnett D – PersonEntity: Name: NameFull: Zimmer TS – PersonEntity: Name: NameFull: Orr AG – PersonEntity: Name: NameFull: Scearce-Levie K – PersonEntity: Name: NameFull: Lewcock JW – PersonEntity: Name: NameFull: Di Paolo G – PersonEntity: Name: NameFull: Sanchez PE IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2022 Jun 11 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1750-1326 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Molecular neurodegeneration Type: main |
| ResultId | 1 |